Literature DB >> 22386596

RAGE binds C1q and enhances C1q-mediated phagocytosis.

Wanchao Ma1, Vivek Rai, Barry I Hudson, Fei Song, Ann Marie Schmidt, Gaetano R Barile.   

Abstract

RAGE, the multiligand receptor of the immunoglobulin superfamily of cell surface molecules, is implicated in innate and adaptive immunity. Complement component C1q serves roles in complement activation and antibody-independent opsonization. Using soluble forms of RAGE (sRAGE) and RAGE-expressing cells, we determined that RAGE is a native C1q globular domain receptor. Direct C1q-sRAGE interaction was demonstrated with surface plasmon resonance (SPR), with minimum K(d) 5.6 μM, and stronger binding affinity seen in ELISA-like experiments involving multivalent binding. Pull-down experiments suggested formation of a receptor complex of RAGE and Mac-1 to further enhance affinity for C1q. C1q induced U937 cell adhesion and phagocytosis was inhibited by antibodies to RAGE or Mac-1. These data link C1q and RAGE to the recruitment of leukocytes and phagocytosis of C1q-coated material.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22386596     DOI: 10.1016/j.cellimm.2012.02.001

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  24 in total

1.  Lack of immunoglobulins does not prevent C1q binding to RGC and does not alter the progression of experimental glaucoma.

Authors:  Qiong J Ding; Amy C Cook; Alina V Dumitrescu; Markus H Kuehn
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-19       Impact factor: 4.799

Review 2.  Unlocking the biology of RAGE in diabetic microvascular complications.

Authors:  Michaele B Manigrasso; Judyta Juranek; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Trends Endocrinol Metab       Date:  2013-09-03       Impact factor: 12.015

3.  Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function.

Authors:  Alex Braley; Taekyoung Kwak; Joel Jules; Evis Harja; Ralf Landgraf; Barry I Hudson
Journal:  J Biol Chem       Date:  2016-03-28       Impact factor: 5.157

Review 4.  Cellular mechanisms and consequences of glycation in atherosclerosis and obesity.

Authors:  Raquel López-Díez; Alexander Shekhtman; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Biochim Biophys Acta       Date:  2016-05-08

5.  Longistatin in tick saliva blocks advanced glycation end-product receptor activation.

Authors:  Takeshi Hatta; Takeharu Miyoshi; Makoto Matsubayashi; M Khyrul Islam; M Abdul Alim; M Abu Anas; M Mehedi Hasan; Yasunobu Matsumoto; Yasuhiko Yamamoto; Hiroshi Yamamoto; Kozo Fujisaki; Naotoshi Tsuji
Journal:  J Clin Invest       Date:  2014-10       Impact factor: 14.808

6.  Putative model for heat shock protein 70 complexation with receptor of advanced glycation end products through fluorescence proximity assays and normal mode analyses.

Authors:  Marcelo Sartori Grunwald; Rodrigo Ligabue-Braun; Cristiane Santos Souza; Luana Heimfarth; Hugo Verli; Daniel Pens Gelain; José Cláudio Fonseca Moreira
Journal:  Cell Stress Chaperones       Date:  2016-11-17       Impact factor: 3.667

Review 7.  C1q: A fresh look upon an old molecule.

Authors:  Nicole M Thielens; Francesco Tedesco; Suzanne S Bohlson; Christine Gaboriaud; Andrea J Tenner
Journal:  Mol Immunol       Date:  2017-06-07       Impact factor: 4.407

Review 8.  Fundamental role of C1q in autoimmunity and inflammation.

Authors:  Myoungsun Son; Betty Diamond; Frances Santiago-Schwarz
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

9.  C1q and HMGB1 reciprocally regulate human macrophage polarization.

Authors:  Myoungsun Son; Amit Porat; Mingzhu He; Jolien Suurmond; Frances Santiago-Schwarz; Ulf Andersson; Thomas R Coleman; Bruce T Volpe; Kevin J Tracey; Yousef Al-Abed; Betty Diamond
Journal:  Blood       Date:  2016-09-28       Impact factor: 22.113

Review 10.  Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors.

Authors:  Hyeon Jin Kim; Mi Suk Jeong; Se Bok Jang
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.